Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




The Ethics of Phase I Trials of Biologic Agents
Link ID 9990
Title The Ethics of Phase I Trials of Biologic Agents
Url http://www.medscape.com/viewarticle/582224?src=rss
Description Early and limited exposure to biologics can cause antibodies to develop and, ultimately, prevent trial participants from gaining any treatment benefit. In this editorial, the author calls for the risks to be clearly stated.
Nature Clinical Practice Gastroenterology & Hepatology
Category Articles > Gastroenterology
Keywords
Date Oct 26, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Does This Patient Have Both Hepatitis B and C?
  A patient who had jaundice many years previously now shows hepatitis B core antibody. What does this mean? Medscape Gastroenterology
Category:   Articles > Gastroenterology


2. A Guide to Enteral Access Procedures and Enteral Nutrition
  Enteral nutrition can be provided during a wide variety of severe illnesses. The current review examines the indications for enteral nutrition as well as enteral access procedures. Nature Reviews Gastroenterology & Hepatology
Category:   Articles > Gastroenterology


3. How Is Opiate-Induced Constipation in Children Treated?
  Pediatric patients requiring opiates are at risk for constipation. What can clinicians do to manage this often-serious condition? Medscape Pharmacists
Category:   Articles > Gastroenterology


4. EASL 2009: Vaccination Against Chronic HCV Promises Sweeping Changes to HCV Management
  A DNA-based therapeutic vaccination against chronic hepatitis C virus (HCV) shows a sustained HCV-specific T-cell response and reduction in viral load. Medscape Medical News
Category:   Articles > Gastroenterology


5. ALT Level Increase Common During HCV Therapy
  Elevations in alanine aminotransferase (ALT) levels late in the course of antiviral therapy of hepatitis C virus (HCV) RNA-negative patients are not unusual and may be associated with virological relapse in some cases, Italian researchers report in the May issue of Hepatology. Reuters Health Information
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS